53 research outputs found
Low-Energy Universality in Atomic and Nuclear Physics
An effective field theory developed for systems interacting through
short-range interactions can be applied to systems of cold atoms with a large
scattering length and to nucleons at low energies. It is therefore the ideal
tool to analyze the universal properties associated with the Efimov effect in
three- and four-body systems. In this "progress report", we will discuss recent
results obtained within this framework and report on progress regarding the
inclusion of higher order corrections associated with the finite range of the
underlying interaction.Comment: Commissioned article for Few-Body Systems, 47 pp, 16 fig
Effects of Pore Walls and Randomness on Phase Transitions in Porous Media
We study spin models within the mean field approximation to elucidate the
topology of the phase diagrams of systems modeling the liquid-vapor transition
and the separation of He--He mixtures in periodic porous media. These
topologies are found to be identical to those of the corresponding random field
and random anisotropy spin systems with a bimodal distribution of the
randomness. Our results suggest that the presence of walls (periodic or
otherwise) are a key factor determining the nature of the phase diagram in
porous media.Comment: REVTeX, 11 eps figures, to appear in Phys. Rev.
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: Results of a prospective double-blind randomized trial
AbstractWe have previously demonstrated a decrease in the incidence of acute graft-versus-host disease (GVHD) with the addition of methotrexate (MTX) to cyclosporine (CSP) and prednisone (PSE) chemotherapy in patients with leukemia. We have now completed a prospective randomized trial comparing the 3-drug regimen (CSP/MTX/PSE, including 3 doses of MTX) to the standard 2-drug regimen (CSP/MTX, including 4 doses of MTX) to investigate the benefit of PSE used up front for the prevention of acute and chronic GVHD. In the trial, 193 patients were randomized and 186 were included in the final analysis. All patients received a bone marrow graft from a fully histocompatible sibling donor. The preparatory regimen consisted of fractionated total-body irradiation (fTBI) and etoposide in all but 13 patients, who received fTBI and cyclophosphamide. The patients were randomized to receive either CSP/MTX/PSE or CSP/MTX. The 2 groups were well balanced with respect to diagnosis, disease stage, age, donor-recipient sex, and parity. In an intent-to-treat analysis, the incidence of acute GVHD was 18% (95% confidence interval [CI] 12-28) for the CSP/MTX/PSE group compared with 20% (CI 10-26) for the CSP/,MTX group (P = .60), with a median follow up of 2.2 years. Overall survival was 65% for those receiving CSP/MTX/PSE and 72% for those receiving CSP/MTX (P = .10); the relapse rate was 15% for the CSP/MTX/PSE group and 12% for the CSP/MTX group (P = .83). The incidence of chronic GVHD was similar (46% versus 52%; P = .38), with a follow-up of 0.7 to 6.0 years. Of interest, 21 patients went off study due to GVHD (5 in the CSP/MTX/PSE group and 16 in the CSP/MITX group [P = .02]), and 11 patients went off study because of alveolar hemorrhage (3 in the CSP/MTX/PSE group and 8 in the CSP/MTX group [P = .22]). The addition of PSE did not result in a higher incidence of infectious complications, bacterial (66% versus 58%), viral (77% versus 66%), or fungal (20% versus 20%), in those receiving CSP/MTX/PSE versus CSP/MTX, respectively. These data suggest that the addition of PSE was associated with a somewhat lower incidence of early posttransplantation complications but did not have a positive impact on the incidence of acute or chronic GVHD or event-free or overall survival.Biol Blood Marrow Transplant 2000;6(3):254-61
- âŠ